The forecasted data for neoplasms mortality among women in Switzerland shows a declining trend over the 2024-2028 period. Starting from 180.8 units per hundred thousand women in 2024, the mortality rate is projected to decrease incrementally each year, reaching 178.8 units by 2028. Compared to the actual data from 2023, there is an observable year-on-year reduction.
- Year-on-year variations: From 2024 to 2025, the mortality rate is expected to decrease by 0.39%. From 2025 to 2026, a decrease of 0.28% is forecasted. The trend persists with a reduction of 0.28% from 2026 to 2027, and a further 0.17% decrease from 2027 to 2028.
- Over the last two years, the rate saw a descending trend, indicating effective healthcare measures or early detection practices starting to show results.
- The compound annual growth rate (CAGR) over the five-year forecasted period is approximately -0.28%, demonstrating a steady decline in the mortality rate of neoplasms among women.
Future trends to watch for include advancements in medical technology, early detection practices, and public health initiatives focused on cancer prevention and treatment, which could further influence the declining trend in neoplasms mortality.
